Review



vvi- or ddd-icd enabled with hm capable of electrogram transmission biotronik icds models lumax  (Biotronik GmbH)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Biotronik GmbH vvi- or ddd-icd enabled with hm capable of electrogram transmission biotronik icds models lumax
    Vvi Or Ddd Icd Enabled With Hm Capable Of Electrogram Transmission Biotronik Icds Models Lumax, supplied by Biotronik GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vvi-icd+enabled+hm+capable+electrogram+transmission/pmc04297469-84-14-26?v=Biotronik+GmbH
    Average 90 stars, based on 1 article reviews
    vvi- or ddd-icd enabled with hm capable of electrogram transmission biotronik icds models lumax - by Bioz Stars, 2026-08
    90/100 stars

    Images



    Similar Products

    vvi- or ddd-icd enabled with hm capable of electrogram transmission biotronik icds models lumax  (Biotronik GmbH)
    90
    Biotronik GmbH vvi- or ddd-icd enabled with hm capable of electrogram transmission biotronik icds models lumax
    Vvi Or Ddd Icd Enabled With Hm Capable Of Electrogram Transmission Biotronik Icds Models Lumax, supplied by Biotronik GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vvi-icd+enabled+hm+capable+electrogram+transmission/pmc04297469-84-14-26?v=Biotronik+GmbH
    Average 90 stars, based on 1 article reviews
    vvi- or ddd-icd enabled with hm capable of electrogram transmission biotronik icds models lumax - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    vvi-icd enabled hm capable electrogram transmission  (Biotronik GmbH)
    90
    Biotronik GmbH vvi-icd enabled hm capable electrogram transmission
    Flow of patients between enrolment and end of follow-up. See text for further details. Patients with ‘irregular early termination’ did not terminate the study with a pre-specified final 24-month follow-up. However, for one patient in the HM OFF group and three patients in the HM ON group, data were available beyond 22 months after implant discharge. HM, Home Monitoring; FU, follow-up; HTX, heart transplantation; ‘upgrade’, <t>implantable</t> <t>cardiac</t> <t>defibrillator</t> upgrade to a cardiac resynchronization device.
    Vvi Icd Enabled Hm Capable Electrogram Transmission, supplied by Biotronik GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/vvi-icd+enabled+hm+capable+electrogram+transmission/pmc04297469-84-17-26?v=Biotronik+GmbH
    Average 90 stars, based on 1 article reviews
    vvi-icd enabled hm capable electrogram transmission - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Flow of patients between enrolment and end of follow-up. See text for further details. Patients with ‘irregular early termination’ did not terminate the study with a pre-specified final 24-month follow-up. However, for one patient in the HM OFF group and three patients in the HM ON group, data were available beyond 22 months after implant discharge. HM, Home Monitoring; FU, follow-up; HTX, heart transplantation; ‘upgrade’, implantable cardiac defibrillator upgrade to a cardiac resynchronization device.

    Journal: European Heart Journal

    Article Title: EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring

    doi: 10.1093/eurheartj/ehu339

    Figure Lengend Snippet: Flow of patients between enrolment and end of follow-up. See text for further details. Patients with ‘irregular early termination’ did not terminate the study with a pre-specified final 24-month follow-up. However, for one patient in the HM OFF group and three patients in the HM ON group, data were available beyond 22 months after implant discharge. HM, Home Monitoring; FU, follow-up; HTX, heart transplantation; ‘upgrade’, implantable cardiac defibrillator upgrade to a cardiac resynchronization device.

    Article Snippet: To be enrolled, patients had to meet the standard indication for a new or replacement VVI- or DDD-ICD enabled with HM technology capable of electrogram transmission (Biotronik ICDs models Lumos, n = 3, or Lumax, all others).

    Techniques: Transplantation Assay

    Resource use during 2 years of implantable cardiac defibrillator follow-up, and average time needed for each of the follow-up activities

    Journal: European Heart Journal

    Article Title: EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring

    doi: 10.1093/eurheartj/ehu339

    Figure Lengend Snippet: Resource use during 2 years of implantable cardiac defibrillator follow-up, and average time needed for each of the follow-up activities

    Article Snippet: To be enrolled, patients had to meet the standard indication for a new or replacement VVI- or DDD-ICD enabled with HM technology capable of electrogram transmission (Biotronik ICDs models Lumos, n = 3, or Lumax, all others).

    Techniques:

    Staff time spent during 2 years of implantable cardiac defibrillator follow-up. The time needed to follow-up the average patient for 2 years did not change with HM. Over the study period, 178 min of staff time per patient were required for HM OFF vs. 176 min in HM ON patients. Significant changes are indicated by an asterisk, and the P -value is mentioned. Left: the time saved by the reduction of in-clinic follow-ups is re-directed to performing remote monitoring, call patients more frequently and discuss patient data more often. Right: only physician time was significantly lower with HM ON, albeit to a small extent.

    Journal: European Heart Journal

    Article Title: EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring

    doi: 10.1093/eurheartj/ehu339

    Figure Lengend Snippet: Staff time spent during 2 years of implantable cardiac defibrillator follow-up. The time needed to follow-up the average patient for 2 years did not change with HM. Over the study period, 178 min of staff time per patient were required for HM OFF vs. 176 min in HM ON patients. Significant changes are indicated by an asterisk, and the P -value is mentioned. Left: the time saved by the reduction of in-clinic follow-ups is re-directed to performing remote monitoring, call patients more frequently and discuss patient data more often. Right: only physician time was significantly lower with HM ON, albeit to a small extent.

    Article Snippet: To be enrolled, patients had to meet the standard indication for a new or replacement VVI- or DDD-ICD enabled with HM technology capable of electrogram transmission (Biotronik ICDs models Lumos, n = 3, or Lumax, all others).

    Techniques: